Cargando…
Ductal Carcinoma In Situ: What Can We Learn from Clinical Trials?
Ductal Carcinoma in situ has been diagnosed more frequently in the last few years and now accounts for approximately one-fourth of all treated breast cancers. Traditionally, this disease has been treated with total mastectomy, but conservative surgery has become increasingly used in the absence of u...
Autores principales: | Fortunato, Lucio, Poccia, Igor, de Paula, Ugo, Santini, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357523/ https://www.ncbi.nlm.nih.gov/pubmed/22649720 http://dx.doi.org/10.1155/2012/296829 |
Ejemplares similares
-
Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012) -
Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004) -
Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004) -
Comment on “Perineural Invasion In Pancreatic Ductal Adenocarcinoma—What Can We Learn From The Past?’’
por: Shen, Xiaofei
Publicado: (2021) -
Ductal Carcinoma In Situ: What the Pathologist Needs to Know and Why
por: Bane, Anita
Publicado: (2013)